Physician profile
Kenneth Chen
NPI 1457517260
$8,526.18
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,733 · 2020: $298 · 2021: $929 · 2022: $2,161 · 2023: $985 · 2024: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujirebio Diagnostics, Incorporated | $3,496.86 | 2019 | |
| Abbott Laboratories | $1,019.43 | 2020-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $869.63 | 2020-2023 | Mounjaro |
| Novo Nordisk INC | $601.34 | 2020-2024 | |
| Dexcom, INC. | $467.16 | 2021-2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $336.08 | 2022-2023 | |
| Amgen INC. | $330.06 | 2020-2023 | Repatha, Evenity, Prolia |
| Abbvie INC. | $302.41 | 2022-2023 | Linzess |
| Alexion Pharmaceuticals, INC. | $286.74 | 2019-2024 | Strensiq |
| Insulet Corporation | $173.91 | 2021-2024 | Omnipod |
| Corcept Therapeutics | $124.96 | 2021 | |
| Mannkind Corporation | $122.57 | 2020-2022 | |
| Medtronic, INC. | $89.83 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $84.25 | 2021-2022 | |
| Radius Health, INC. | $72.32 | 2022-2024 | Tymlos |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $43.49 | 2022-2023 | Tirosint, Licart |
| Medtronic Minimed, INC. | $42.45 | 2020 | |
| Valeritas, INC. | $22.57 | 2019 | |
| Recordati_rare_diseases_inc. | $20.06 | 2022 | |
| Eusa Pharma (US) LLC | $20.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.